Knowledge Hub · miniGITA Dual
A radio-TLC scan measures whether the labelling chemistry worked. A gamma spectrum measures whether the radionuclide you labelled with is what you intended. For theranostic-era isotopes — Lu-177, Ga-68 — both failure modes are real. This page is why paired release records matter and what the AERB inspector reads off them.
Why this matters
Why two release checks
%RCP measures the fraction of activity bound to the intended radiopharmaceutical. It does not measure whether that activity is the radionuclide you intended to use. A Lu-177 batch contaminated with Lu-177m has the same %RCP but a different gamma spectrum. A Ga-68 batch with Ge-68 breakthrough has the same %RCP but a different spectrum. For theranostic isotopes where parent-breakthrough is a real failure mode, both checks belong on every release record.
Based on: IAEA TRS 466 — Quality Assurance for PET and PET/CT Systems; Eur.Ph. radiopharmacy monographs (RCP + radionuclidic identity sections).
Read source ↗Lu-177 parent contamination
No-carrier-added Lu-177 is produced via Yb-176 → Lu-177 chemistry with downstream separation. Carrier-added Lu-177 is produced by direct Lu-176(n,γ) neutron activation and inevitably contains Lu-177m (160 d half-life, long-lived contaminant). Both produce the same radio-TLC trace. Only the gamma spectrum tells them apart — Lu-177m sits at 228 keV while pure Lu-177 sits at the 113 / 208 keV doublet. The nuclide-identity check is what distinguishes n.c.a. from c.a. on the batch record.
Based on: EANM Technologist Guide — Quality Control of Radiopharmaceuticals; ICRP Publication 107 nuclear-decay data.
Read source ↗Ga-68 generator breakthrough
Ge-68 / Ga-68 generators slowly leak the long-lived parent (Ge-68, t½ 271 d) into the eluate. Eur.Ph. specifies a parent-breakthrough limit (typically < 0.001 % activity at expiry). The breakthrough check is a delayed-spectrum measurement — let the Ga-68 decay (t½ 68 min), then measure the residual gamma spectrum. Any Ge-68 contamination shows up as the persistent 511 keV annihilation line after Ga-68 decay. The Dual instrument carries this method in the library; every Ga-68 batch can carry the breakthrough check on its release record.
Based on: Eur.Ph. monograph 2482 — Gallium-68 chloride; IAEA TRS 466 Ga-68 PET tracer QC chapter.
Read source ↗Paired audit trail
Two separate instruments produce two separate records — radio-TLC software writes one record, gamma-spectrometry software writes another. Reconciliation happens by hand at the end of the day. The Dual instrument writes both checks into one 21 CFR Part 11 audit trail under one signed release. The batch record carries the paired data on one timestamp; the AERB inspector reads one record per batch.
Based on: US FDA 21 CFR Part 11 — Electronic Records, Electronic Signatures; AERB Safety Code for Nuclear Medicine Facility.
Read source ↗One IQ / OQ / PQ
Two separate instruments require two installation qualifications, two operational qualifications, two performance qualifications and two annual revalidation cycles. The Dual instrument requires one of each — the IQ covers both detection chains, the OQ covers paired-release execution, the PQ covers per-isotope methods. One pack, one revalidation cadence, one inspection-ready evidence binder.
Based on: EU GMP Annex 15 — Qualification and Validation; IAEA hospital-radiopharmacy operational guidance.
Read source ↗AERB inspection fit
AERB inspection of a hot-lab radiopharmacy programme reads the batch-release records to verify two things: (1) every batch had a radiochemical-purity check against the monograph, and (2) every batch had a radionuclidic-identity check appropriate to the isotope. When both checks live on the same paired record, the inspector reads one document per batch. When they live on two separate systems, the inspector has to cross-reference — and finds the reconciliation gap before the radiopharmacist does.
Based on: AERB Safety Code for Nuclear Medicine Facility — release-record expectations.
Read source ↗IAEA, Eur.Ph., EANM and AERB documents anchoring paired radiochemical-purity and nuclide-identity QC.
IAEA technical report covering PET radiopharmacy QC including paired radiochemical-purity and radionuclidic-identity expectations.
European Pharmacopoeia general + per-isotope monographs defining radiochemical-purity AND radionuclidic-identity thresholds.
EANM technologist-facing guide on radiopharmaceutical QC including nuclide-identity QC methods.
Indian regulatory framework for nuclear-medicine facility licensing including hot-lab QC and release-record expectations.